Assessment of BMS-986094-induced chronic cardiotoxicity using human iPS cell-derived cardiomyocytes

被引：0
|
作者：
Yanagida, Shota [1 ,2 ]
Satsuka, Ayano [1 ]
Hayashi, Sayo [1 ]
Ono, Atsushi [2 ]
Kanda, Yasunari [1 ]
机构：
[1] Natl Inst Hlth Sci, Div Pharmacol, Kawasaki, Kanagawa, Japan
[2] Okayama Univ, Graduated Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama, Okayama, Japan
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2023年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SP104
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Evaluation of doxorubicin-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Hunault, Marion
    Legrand, Christophe
    Castagne, Vincent
    Goineau, Sonia
    TOXICOLOGY LETTERS, 2017, 280 : S255 - S255
  • [32] Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Lee, Sujeong
    Lee, Hyang-Ae
    Choi, Sung Woo
    Kim, Sung Joon
    Kim, Ki-Suk
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 296 : 42 - 53
  • [33] microRNAs as signatures of structural cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Gryshkova, V.
    Palmer, J.
    Smith, A.
    Burrier, R.
    Colwell, M.
    Delaunois, A.
    da Costa, A. Nogueira
    Valentin, J. -P.
    TOXICOLOGY LETTERS, 2018, 295 : S58 - S58
  • [34] Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity
    Sharma, Arun
    McKeithan, Wesley L.
    Serrano, Ricardo
    Kitani, Tomoya
    Burridge, Paul W.
    del Alamo, Juan C.
    Mercola, Mark
    Wu, Joseph C.
    NATURE PROTOCOLS, 2018, 13 (12) : 3018 - 3041
  • [35] Cardiotoxicity evaluation using three-dimensional cardiac tissues consisting of human iPS cell-derived cardiomyocytes and fibroblasts by cell coating technique
    Tadano, Kiyoshi
    Kazusa, Katsuyuki
    Takamatsu, Kazuhiko
    Naraoka, Hitoshi
    Takeda, Maki
    Akashi, Mitsuru
    Miyagawa, Shigeru
    Sawa, Yoshiki
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
  • [36] A model of anthracycline-induced cardiotoxicity using induced pluripotent stem cell-derived cardiomyocytes
    Streckfuss-Boemeke, K.
    Haupt, L.
    Fomin, A.
    Wagner, S.
    Sossalla, S.
    Cyganek, L.
    Linke, W.
    Maier, L. S.
    Guan, K.
    Hasenfuss, G.
    EUROPEAN HEART JOURNAL, 2015, 36 : 609 - 609
  • [37] Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes
    Louisse, Jochem
    Wust, Rob C. I.
    Pistollato, Francesca
    Palosaari, Taina
    Barilari, Manuela
    Macko, Peter
    Bremer, Susanne
    Prieto, Pilar
    TOXICOLOGY IN VITRO, 2017, 42 : 182 - 190
  • [38] Molecular Characterization of Induced Pluripotent Stem (iPS) Cell-Derived Cardiomyocytes
    Ohno, Yohei
    Yuasa, Shinsuke
    Egashira, Toru
    Seki, Tomohisa
    Hashimoto, Hisayuki
    Toyama, Shugo
    Yoon, Sung Han
    Arai, Takahide
    Hao, Chen
    Tanaka, Tomofumi
    Hattori, Fumiyuki
    Yae, Kojiro
    Murata, Mitsushige
    Ogawa, Satoshi
    Yamanaka, Shinya
    Fukuda, Keiichi
    CIRCULATION, 2009, 120 (18) : S765 - S765
  • [39] Proarrhythmia risk assessment by electro-mechanical window in human iPS cell-derived cardiomyocytes
    Yanagida, Shota
    Satsuka, Ayano
    Hayashi, Sayo
    Ono, Atsushi
    Kanda, Yasunari
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2022, 117
  • [40] A Recipe for T-Tubules in Human iPS Cell-Derived Cardiomyocytes
    Cadet, Jean Scotty
    Kamp, Timothy J.
    CIRCULATION RESEARCH, 2017, 121 (12) : 1294 - 1295
12345